SUMMARY In Finland's North Karelia region a community-based program for control of hypertension was administered for 5 years. Afterward, drug treatment and the impact of such treatment on control of blood pressure were studied in a cross-sectional survey. The study population (n = 10,199) consisted of a 6.6% random sample of people aged 30-64 years in North Karelia (program area) and Kuopio (reference area). Rate of participation was about 90%. The methods included questionnaire, personal interview, and clinical examination. In North Karelia, 24% of the men and 25% of the women were hypertensives (blood pressure ^ 175 mm Hg systolic and/or 100 mm Hg diastolic, or currently on antihypertensive drug therapy), compared with 33% of the men and 29% of the women in the reference area. In North Karelia, 48% of the male hypertensives and 67% of the female hypertensives were on drug therapy, compared with 32% and 54%, respectively, in the reference area. Of the total population in each area, 14% in North Karelia currently used drugs, compared with 13% in the reference area. Diuretics and beta-blockers were the drugs most commonly prescribed; men used beta-blockers more often than women did. In terms of quantity of medication, type of drugs, and compliance, the differences between the two areas were small. Control of blood pressure, however, was clearly better in North Karelia than in the reference area for hypertensives and drug users and for both men and women. Therefore, compared with the traditional system, organized hypertension care results in more successful treatment. 
D URING the past 3 decades, antihypertensive
drugs have proved their efficacy and importance in treating elevated blood pressure. The Veterans Administration studies' 2 confirmed the benefits of using drugs for treating severe and moderate hypertension. Recently, treatment of mild hypertension has also been shown to be beneficial in terms of morbidity and mortality. 3 - 4 Previous population surveys, however, have confirmed that only a portion of the treated hypertensives become normotensive. 5 " 7 Nevertheless, hypertension care has improved during the last decade. 8 -9 The ever-increasing selection of drugs for lowering blood pressure provides opportunities for organizing treatment in many ways. No standard or universal treatment model has been adopted. In Northern Europe the preferred drugs have been diuretics and betablockers; often as the third choice, a vasodilator in a stepwise schedule is recommended. The goal of drug selection should be to find a drug or a drug combination that is efficacious and produces no, or at least negligible, side effects. The choice between a diuretic and a beta-blocker as the first drug should be based on therapeutic considerations. If no special therapeutic reason favors one or the other, then other aspects (e.g., economy) should also be taken into account.
According to our previous findings, about twothirds of the total costs of hypertension control in the community is for drugs. 10 Since about 345,000 patients in Finland (7.5% of the total population) are entitled to antihypertensive drug therapy fully reimbursed by the Social Insurance Institution, cost is extremely important.
Active attempts to control hypertension in the community naturally increase the actual number of persons treated. When at the same time various new drugs are promoted by the pharmaceutical industry, there is a need for accurate measurements of the quantity and the quality of drug treatment in the population.
In 1972-1977 a community-based program for control of hypertension as part of a comprehensive CVD control program was carried out in North Karelia, Eastern Finland. The program was evaluated by studying large, random, independent, cross-sectional population samples at the onset and at the end of the period in North Karelia and in a matched reference area. The main results from these surveys concerning the effects of the hypertension program have been published previously. 8 "" 13 According to them, the mean casual blood pressure among 30-to 59-year-old male population changed in North Karelia from 149/92 to 143/89 mm Hg and remained unchanged (146/93 mm Hg) in the reference area. The respective changes among women were from 153/92 to 141/86 mm Hg in North Karelia and from 147/91 to 143/89 mm Hg in the reference area.
The purpose of this study was to: 1) evaluate the status of antihypertensive drug treatment and its impact on hypertension control in North Karelia after the 5-year community-based control program for control of hypertension; and 2) compare these results with the results obtained from the matched reference area representing the traditional system of antihypertensive therapy in Finland using the results from the crosssectional survey in 1977.
Subjects and Methods

Study Population
The study material was a representative 6.6% population sample of people aged 30-64 years in the counties of North Karelia (180,000 inhabitants) and a matched reference area (Kuopio County; 250,000 inhabitants), both in Eastern Finland. The samples were drawn randomly from the National Population Register. Participation rate in the survey in 1977 was 89% (n = 4123) in North Karelia and 90% (n = 6076) in the reference area. 13 
Patient Surveys and Clinical Assessment
The survey was a combination of questionnaire, personal interview, and clinical examination. International recommendations were followed as closely as possible.
14 The methods used in the two areas were the same. Before the examination, subjects received a letter containing an explanation of the study, an invitation to the examination, and the questionnaire. At examination in local health centers, casual blood pressure from the right arm was measured before venous puncture and after 5 minutes of rest in a sitting position. A sphygmomanometer with a cuff 23 cm long and 13 cm wide was used. Blood pressure values were recorded to the nearest 2 mm Hg, and the measurement was made during one continuous deflation. The fifth phase (disappearance of the Korotkoff sounds) was recorded as the diastolic blood pressure. Blood pressure was measured by specially trained nurses, who were trained together for 5 days before the survey. Training included details about the study design and survey methods (checking questionnaires, taking blood samples, and measuring blood pressure). Training for blood pressure measurement included theory of measurement and possible sources of error, written material about methods, and practical exercises. During the field survey, daily means of blood pressures and distribution of the last digits of the blood pressure values taken by each nurse were followed continuously by the research group. The observer influence on blood pressure level was studied using several statistical methods. These studies showed that the effect of interobserver variation was negligible. 12 All subjects classified as hypertensives at the examination (160 mm Hg systolic and/ or 95 mm Hg diastolic or on drug treatment) were invited to a second examination within a few weeks. If the subject did not attend the first examination, another invitation was sent.
Drug Information and Patient Compliance
To assess current drug treatment for hypertension, each subject was asked: "Are you currently using any antihypertensive drugs?". For the second visit people using antihypertensive drugs were asked to bring along all their prescriptions. From these prescriptions information concerning trade name, strength of the tablets, and daily dosage were recorded according to a standard code list. Detailed drug information was available for 81% of the persons on drug therapy in North Karelia and for 91 % in the reference area (participation rate for the second visit was lower in NK).
In addition, all prescriptions for a sample of 310 hypertensives using drugs in the study areas were checked retrospectively for a 1-year period, from June 1976 to June 1977, in cooperation with the Social Insurance Institution, which stores all prescription duplicates from the pharmacies for reimbursement. The prescription study showed that, with regard to antihypertensive drug treatment, those who did not respond to the survey did not differ significantly from those who did respond. 13 Compliance in taking drugs was assessed from the prescription study and was based on amount of time between dispensing dates. The actual treatment period was compared with the theoretical treatment period, during which time the patients should have used the medicine if they had followed instructions exactly. The method used has been presented elsewhere. 16 Analysis of Risk for Coronary Heart Disease Risk for coronary heart disease (CHD) was estimated on the basis of three major risk factors -blood pressure, serum cholesterol, and smoking (CHD risk estimate) -using the method (multiple logistic function analysis) described by Walker and Duncan. 17 
Treatment of Hypertension in North Karelia
During the hypertension program carried out between 1972-77 in North Karelia, people with elevated blood pressure values with fixed criteria were registered following procedures worked out by the Project. These subjects were then followed up by special hypertension dispensaries which were established at each local health center following recommendations of the Project. The physicians of the health centers were responsible for the diagnostic work-up and the medical treatment of the hypertensive. The regular follow-up and systematic health education were carried out by specially trained public health nurses of the staff of the dispensaries. 18 Antihypertensive drugs were used as the main means for reducing high blood pressure. In addition, patients were given general health education about improving diet, stopping smoking, and reducing stress. In each case individual physicians chose whether to initiate drug treatment or not and decided which drugs would be prescribed. The program only suggested general guidelines for treatment and provided continuous training of physicians and nurses. The objective of drug treatment was to reduce blood pressure as much as possible without major side-effects.
Results
The proportion of hypertensives (i.e., BP > 175 and/or 100 mm Hg or currently on antihypertensive drugs) in the total population was 24% for males and 25% for females in North Karelia and 33% for males and 29% for females in the reference area (table 1) .
More women than men and slightly more patients in North Karelia than in the reference area were currently taking drugs for hypertension (table 2). In the youngest group (30-39 years), 4% of the population in North Karelia and 2% in the reference area were currently on drug treatment. In groups aged 40-49 years and 50-59 years, 11% and 23%, respectively, were on drug treatment with no differences between the two areas. In the oldest group (60-64 years) more patients were treated in North Karelia than in the reference area. In all age groups, considerably more hypertensives were currently on drug therapy in North Karelia than in the reference area. Of the female hypertensives, 67% in North Karelia and 54% in the reference area were on drug therapy; the corresponding figures for males were 48% and 32%, respectively. About 30% of those who had at sometime used antihypertensive drugs were not currently using them; no differences were found between the two areas.
Drug Treatment
Diuretics and beta-blockers were the most commonly used drugs in both areas (table 3) . Beta-blockers were used slightly more in the reference area than in North Karelia. In both areas, beta-blockers were used more by men than by women.
Methyldopa was used more in North Karelia than in the reference area; vasodilators and clonidine were used more in the reference area. Use of diuretics increased with increasing age, except among women in the reference area; this was obviously due to extensive use of fixed antihypertensive combinations containing diuretics by the oldest group. Beta-blockers were prescribed more often for younger people than for older patients. Vasodilators were also used most often by younger hypertensives and by men. Fixed antihypertensive combinations were prescribed more often for women than for men and for older than for younger patients.
In North Karelia 45% of patients treated used only one drug, compared with 41% in the reference area (table 4) . In North Karelia, 52% of these patients on monotherapy used diuretics, and 32% used betablockers; men used more beta-blockers than women did. In the reference area beta-blockers were used more often than diuretics among those with one drug. Combination therapy with two drugs was used by 39% of the patients in North Karelia and 41% in the reference area. The most usual combination was diuretic and beta-blocker, making up 44% and 45% of all twodrug combinations. In North Karelia diuretics were combined with methyldopa for almost 29% of the patients with two-drug combinations; in the reference area methyldopa and diuretics were used for only 16% of these patients. On the other hand, the combinations of diuretic and clonidine were more frequently prescribed in the reference area.
In North Karelia 16% of the patients used combinations with three or more drugs compared with 18% in the reference area. Diuretics and beta-blockers were the basic elements, with surprisingly few patients using vasodilators in addition. Some inappropriate drug combinations were also found, e.g., a combination of four different drugs, not including a diuretic, and a combination of two different beta-blockers. The number of drug preparations in use simultaneously and numbers of tablets prescribed per day according to age and sex are seen in figure 1 . In North Karelia men had an average of 1.6 ± 0.05 (SEM) drug preparations and in the reference area 1.7 ± 0.04; corresponding numbers for women were 1.5 ± 0.04 and 1.6 ± 0.03, respectively. In both areas, men had more drugs than women did, except for the oldest group in the reference area where the number of drugs was the same for both men and women. The greatest differences between the two areas are seen for men aged 40-49 years and for women 30-39 years. There is, however, no consistent trend distinguishing the two areas. Among men some differences between age groups seem clear; in both areas men aged 40-49 years had the most drugs, and also women aged 40-49 years in North Karelia had most drugs. The average number of tablets prescribed per day for men was 3.1 ± 0.13 (SEM) in North Karelia and 3.1 ± 0.11 in the reference area; the women in North Karelia had 2.8 ± 0.10 and in the reference area 2.9 ± 0.08. Comparison of the level of estimated CHD risk and number of drugs indicated that the higher the CHD risk, the more antihypertensive drugs were used (table 5) .
Patient compliance based on the 1 -year follow-up of prescriptions showed that compliance in the reference area was slightly better than in North Karelia. No significant differences between the sexes were found (table 6). TABLE 
Number of Drug Preparations in Use According to Level of Estimated CHD Risk in 1977
No. of drugs Control of Blood Pressure Control of blood pressure among hypertensives was clearly more adequate in North Karelia among both men and women (table 7) . In North Karelia 19% of male hypertensives had a DBP < 95 mm Hg, 51% were between 95 and 104 mm Hg, and 30% had 105 mm Hg or more; for women the respective percentages were 40%, 41 %, and 19%. In the reference area, 8% of male hypertensives had an adequately controlled (DBP < 95 mm Hg) blood pressure, 43% medium (95-104 mm Hg), and 48% a poor control (105 mm Hg or more), and for women 21%, 43%, 36%, respectively. Blood pressure control was better for women and for older groups in both areas.
Outcome of antihypertensive drug treatment differed distinctly in the two areas (table 8). The percentage of men with poor outcome (casual DBP ^ 105 mm Hg) was 27% in North Karelia and 47% in the reference area; poor outcome for women was 13% and 36%, respectively. The number of patients with blood pressure under poor control increased somewhat with the number of drugs in use. This might reflect the fact that patients whose hypertension is more resistant to treatment are referred to combination therapy. Of the men on monotherapy 21 % in North Karelia and 40% in the reference area had diastolic blood pressures over 105 mm Hg; for women the respective percentages were 12% and 36%. In the outcome of treatment between the different drug groups only small differences were found.
Discussion
Prevalence of Drug Use
The prevalence of hypertension in the population in 1977 was somewhat higher in the reference area than in North Karelia. Comparing these results with those obtained in the 1972 baseline survey, the proportion of persons classified as hypertensives among people aged 30-59 years decreased in North Karelia from 29% to 23% among males and from 35% to 22% among females, while in the reference area the proportion increased from 30% to 32% among males but decreased from 28% to 26% among females. 12 In North Karelia, the proportion of hypertensives on drug treatment, however, was significantly higher than in the reference area in 1977. Thus, the proportion of the total population on drug therapy was almost the same in both areas. One possible explanation for the change in number of hypertensives could be that a proportion of people earlier classified as hypertensives in North Karelia are not anymore hypertensive, i.e. that treatment of milder forms of hypertension at an early stage might actually "cure" some patients.
Compared to the situation in the baseline survey in 1972, there had been a net increase of 103% in numbers of male hypertensives (aged 30-59 years) on drug therapy in North Karelia and a 64% net increase among female hypertensives, compared to the reference area." Despite this good progress in the number of hypertensives on drug therapy in North Karelia, half the males classified as hypertensives were not currently on drug treatment, and even fewer of the male hypertensives in the reference area were being treated.
Patterns of Drug Use
In North Karelia diuretics were used as the first choice of antihypertensive drugs for both sexes; in the reference area beta-blockers were preferred especially for men. Beta-blockers were also used most often for younger age groups in both areas, in accordance with current recommendations. Of the diuretics used, about 70% were combination diuretics including potassiumsparing agents." In general, diuretics and beta-blockers were the most commonly used drugs in both areas for all age groups.
Use of methyldopa decreased throughout Finland in the late 1970s, 20 partly owing to introduction of betablockers. According to our results, methyldopa is used less often in the reference area than in North Karelia. This indicates that some methyldopa use has been replaced by clonidine in the reference area. The relatively infrequent use of vasodilators, especially among women, is surprising in the study area, since the general recommendation was to use vasodilators as the third step in combination therapy.
Fixed combination preparations were used relatively infrequently, but were more common among women and older people. This is probably due mainly to the traditions of therapy among women. (These drugs have been on the market a relatively long time, and women have generally started drug treatment earlier than men.) Monotherapy was as common as combinations of two drugs; nearly half the two-drug combinations included a diuretic and a beta-blocker, reflecting general recommendations for drug therapy. No great differences were found between the two areas in the number of drug preparations and numbers of tablets used. In both areas men had more tablets and preparations than women did.
Control of Blood Pressure
This type of cross-sectional survey limits the conclusions we can make on the outcome of treatment. The outcome does not necessarily reflect the efficacy of the various drugs or combinations, because the pretreatment levels of blood pressure are not available, and eventual changes in drug therapy are also unknown. Casual blood pressure measurements might give higher values than if they had been measured several times.
Control of diastolic blood pressure among hypertensives was clearly better for women than for men and for older people than for young in both areas. The difference between sexes is also seen among drug users. Men used more tablets and drugs; but on the other hand, the outcome of therapy was better among women. Therefore, one may question whether new drugs were added mechanically to the treatment of men without checking other possible reasons for the poor results. Differences in patient compliance do not satisfactorily explain these differences in outcome.
Another explanation might be that physicians began to treat women at lower blood pressure levels than men, in spite of recommendations by national experts on hypertension, emphasizing that drug treatment for men should begin earlier and at lower blood pressure level. Poorer outcome among men has also been found in other studies. 49 With the limitations mentioned above in mind, the results of therapy did not seem to depend much on the type of drug therapy.
The differences in the outcome of treatment were obvious between the areas, the results being better in the study area than in the reference area both among hypertensives and users of antihypertensive drugs. This difference between areas was not due to pharmacological reasons (i.e., a certain drug or drug combination, dosage, or compliance). According to the physicians, therapy was begun at lower blood pressure levels in North Karelia than in the reference area. 13 This may partly explain the differences in outcome of therapy in the two areas. Other possible nonpharmacological reasons include the care of patients (operationally difficult to define), health education, differences in attitudes and knowledge about hypertension, differences in the organization of the care (including the frequency of visits to health care personnel). According to another study of the same population 12 the utilization of health care services was more rational in North Karelia than in the reference area, i.e., both too frequent visits and blood pressure measurements were fewer and "no shows" were less common in North Karelia than in the reference area.
Thus, systematized and renewed hypertension care in the study area, which included health education of the public, training of personnel, establishment of hypertension dispensaries run by specially trained public health nurses, and a supporting information system, 8 ' l2 ' 18 seem to explain to a great extent the differences between the study and the reference area. The roles of different factors within the systematic care program are, however, difficult to assess.
Recent results from the Hypertension Detection and Follow-Up Program 4 agree with the conclusions of the hypertension program of the North Karelia project: organized care results in better treatment than does the traditional system. A systematically organized program of hypertension care helps physicians make better decisions about initiation of treatment; thus unnecessary drug treatment and inappropriate drug combinations are avoided. This is important not only for treated hypertensives, but especially for borderline cases, who are expected to achieve the required decrease in blood pressure through other means than drugs (e.g., weight control and salt reduction). Careful selection of drugs for lowering blood pressure is important at the individual level, but other nonpharmacological factors are at least as important, both at the individual and community levels. We need more research on factors that cause unsatisfactory results in antihypertensive drug therapy.
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